Skip to content

TB research is research to save the lives of people with HIV

Once-daily darunavir approved in Europe for patients starting HIV treatment

Untreated HIV depletes CD4 cells in semen – renders men more vulnerable to STIs

HIV treatment during pregnancy does not increase risk of birth abnormalities – even when efavirenz included

Simultaneous treatment of HIV and TB improves survival

Microbicide uses RNA interference technology to halt viral infection

Study supports use of 21 days doxycycline to treat LGV

Repeated exposure to HIV during oral sex elicits HIV-neutralising antibodies in HIV-negative men

Cancer is an increasingly important cause of death in people with HIV